|
5th International AIDS Society Conference on HIV Pathogenesis and TreatmentCape Town - July 19 - 22, 2009 |
THE APPLICATION OF EXISTING AND EMERGING TESTING TECHNOLOGIES TO MORE RAPIDLY DETECT HIV INFECTION AMONG HIGH-RISK POPULATIONS
IAS Conf HIV Pathog Treat 2009 Jul 19-22;5th: Abstract No. MOPDD101
K. Roe1, D. Gluth1, S. Gibson1, C. Hall1, T. Ryan1, J. Auerbach2, S. Facente3
1San Francisco AIDS Foundation, Magnet, San Francisco, United States, 2San Francisco AIDS Foundation, Science & Public Policy, San Francisco, United States, 3San Francisco Department of Public Health, AIDS Office, San Francisco, United States
BACKGROUND: Rates of new HIV infections in San Francisco disproportionately affect MSM, with high incidence (2%) and prevalence (27%) rates. Individuals with acute HIV infection (AHI) account annually for an estimated 25% of new infection transmissions. Given limitations of existing testing technology and the need to more rapidly clarify test validity, new applications of existing and emerging HIV testing technologies are required to provide more timely and accurate infection verification — including AHI — to individuals in high incidence and prevalence settings.
METHODS: Magnet, a program of the SF AIDS Foundation, in collaboration with the local health department and researchers, designed a testing algorithm to maximize existing and emerging technologies for use in the community setting with high-risk populations. A matrix of oral fluid and blood-based rapid antibody tests provides accelerated serostatus verification. Using a risk-based model, risk assessment and counseling information triangulates to identify individuals at greatest risk for AHI and eligible for RNA testing, capable of detecting infection within 2-4 weeks after exposure.
RESULTS: Utilization of the oral fluid/blood matrix has accelerated infection verification from 7 days to 45 minutes. In 2007 and 2008, a total of 5,294 rapid oral fluid antibody tests were conducted with 95 (1.8%) confirmed positive in that time frame. RNA testing further detected 9 (1.7%) cases in acute infection that would not have been detected using antibody testing.
CONCLUSIONS: Health care and prevention service providers are looking for enhanced rapid testing technologies to screen for AHI. New testing technologies must continue to be explored and advances quickly adapted to reach those at greatest risk in practical and community-relevant ways, in a variety of settings. Lessons learned at Magnet are instructive for the application of enhanced HIV testing and screening techniques in other high incidence and prevalence populations.
Download PDF of this abstract.
Download PDF Poster Presentation.
Download Power Point Presentation.
2009-07-22
MOPDD101
Operations Research to Improve Laboratory Diagnosis and Monitoring
Copyright © 2009 - International AIDS Society (IAS). All information and content relating to the abstracts from the 5th International AIDS Society Conference on HIV Pathogenesis and Treatment, such as text, graphics, logos, button icons, images, audio clips, and software is protected by copyright. Permission is hereby granted for the non-commercial use or reproduction of the information on this web site, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, AIDS Walk of Orange County, and donations from users like you. Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. Permission is hereby granted for the non-commercial use or reproduction of the information herein, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.